Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. drugmaker’s respiratory treatments.
Recent Posts
- Hassett Fed chair odds fall, Warsh chances surge on Kalshi after Trump comments
- Trump says Kevin Warsh is at top of Fed chair candidate list, president should be consulted on rates
- Coinbase to soon unveil prediction markets powered by Kalshi, source says
- There’s still time to maximize the 0% capital gains bracket for 2025. Here’s what to know
- Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC; pot stocks surge